Insider · CIK 0002040446
Sealbond Ltd
Files at DWTX (Dogwood Therapeutics, Inc.). First filing -, latest -.
Sealbond Ltd files SEC Form 4 as director and 10% owner at DWTX (Dogwood Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sealbond Ltd has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | DWTX Dogwood Therapeutics, Inc. | CConversion Common Stock | +21,610,950 | - | - | 21,822,333 | Nov 25, 2025 |
| Nov 21, 2025 | DWTX Dogwood Therapeutics, Inc. | CConversion Common Stockindirect: By Conjoint Inc. | +2,842,638 | - | - | 2,842,638 | Nov 25, 2025 |
| Nov 21, 2025 | DWTX Dogwood Therapeutics, Inc. | CConversion Series A Preferred Stockderivative | -2,161 | $0.00 | $0 | 0 | Nov 25, 2025 |
| Nov 21, 2025 | DWTX Dogwood Therapeutics, Inc. | CConversion Series A-1 Preferred Stockderivativeindirect: By Conjoint Inc. | -284 | $0.00 | $0 | 0 | Nov 25, 2025 |
Questions about Sealbond Ltd
Answered from the filings on this page, as of the latest one.
Is Sealbond Ltd buying or selling?
Sealbond Ltd has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sealbond Ltd's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sealbond Ltd has 0.
Where does Sealbond Ltd file Form 4?
Sealbond Ltd has filed Form 4 at DWTX (Dogwood Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.